Literature DB >> 4013861

Evidence of more rapid stimulus evaluation following cigarette smoking.

J A Edwards, K Wesnes, D M Warburton, A Gale.   

Abstract

Experienced male smokers (greater than 15 cigarettes daily) performed a rapid visual information processing (RVIP) task requiring the detection of sequences of three consecutive odd or even digits in a series presented singly on a TV screen, at a rate of 100 digits/minute. Approximately 80 targets occurred every 10 minutes. All subjects took part in three test sessions: (a) Baseline of 10 minutes on the RVIP task, (2) treatment phase of 10 minutes smoking one cigarette (0.9mg or 1.5mg standard machine delivery of nicotine) or not smoking (NS), (3) posttreatment phase of 20 minutes on the task. Before these morning sessions subjects abstained from smoking for at least 12 hours. Smoking increased the number of correct detections and decreased response time compared with pre-smoking baseline and NS sessions. Analysis of vertex Event-Related Potentials to correct detections revealed a significant reduction in P300 latency following smoking compared to NS sessions. It is suggested that smoking has speeded up stimulus evaluation processes in these individuals. These data are consistent with the common self-report by smokers that smoking aids concentration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013861     DOI: 10.1016/0306-4603(85)90017-6

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  24 in total

1.  Enhancement of continuous performance task reaction time by smoking in non-deprived smokers.

Authors:  W S Pritchard; J H Robinson; T D Guy
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Smoking deprivation in "early" and "late" smokers and memory functions.

Authors:  N Roth; B Lutiger; M Hasenfratz; K Bättig; M Knye
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

4.  Smoking impacts on prefrontal attentional network function in young adult brains.

Authors:  Francesco Musso; Franziska Bettermann; Goran Vucurevic; Peter Stoeter; Andreas Konrad; Georg Winterer
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

5.  Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.

Authors:  G Dunbar; P H Boeijinga; A Demazières; C Cisterni; R Kuchibhatla; K Wesnes; R Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

6.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

7.  Positive effects of nicotine on cognition: the deployment of attention for prospective memory.

Authors:  J M Rusted; R Sawyer; C Jones; S L Trawley; N L Marchant
Journal:  Psychopharmacology (Berl)       Date:  2008-09-25       Impact factor: 4.530

8.  Faster P300 latency after smoking in visual but not auditory oddball tasks.

Authors:  M E Houlihan; W S Pritchard; J H Robinson
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

9.  P300 as a measure of cognitive dysfunction from occupational and environmental insults.

Authors:  J B Pan; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  1999-10       Impact factor: 3.674

10.  Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.

Authors:  H V Semlitsch; P Anderer; B Saletu
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.